PharmGen Science, Inc. (KRX:004720)

PharmGen Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 18, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	89,513	74,179	111,355	105,470	159,511	165,783
Market Cap Growth	9.06%	-33.39%	5.58%	-33.88%	-3.78%	123.51%
Enterprise Value	94,859	78,578	127,335	126,753	178,736	154,760
Last Close Price	4085.00	4090.00	6200.00	6680.00	10500.00	11300.00
PE Ratio	760.20	26.58	18.29	1.51	4.91	17.98
PS Ratio	0.52	0.43	0.67	0.70	1.45	1.72
PB Ratio	0.36	0.30	0.48	0.51	1.26	1.98
P/TBV Ratio	0.36	0.30	0.48	0.51	1.26	1.99
P/FCF Ratio	-	50.61	35.09	-	-	-
P/OCF Ratio	-	31.11	20.47	-	20.49	61.96
EV/Sales Ratio	0.55	0.46	0.76	0.84	1.63	1.60
EV/EBITDA Ratio	13.69	5.15	9.52	11.76	-	146.36
EV/EBIT Ratio	41.18	7.40	13.95	17.10	-	-
EV/FCF Ratio	-48.90	53.62	40.13	-	-	-
Debt / Equity Ratio	0.08	0.16	0.16	0.19	0.38	0.26
Debt / EBITDA Ratio	1.36	2.55	2.84	3.66	-	20.24
Debt / FCF Ratio	-	26.60	11.96	-	-	-
Net Debt / Equity Ratio	0.02	0.00	0.00	0.10	0.11	-0.11
Net Debt / EBITDA Ratio	0.37	0.04	0.04	1.82	-7.70	-8.55
Net Debt / FCF Ratio	-2.75	0.37	0.17	-1.75	-0.60	5.44
Asset Turnover	0.50	0.49	0.51	0.56	0.62	0.82
Inventory Turnover	2.28	2.41	3.32	3.87	3.11	2.85
Quick Ratio	1.26	1.19	1.16	0.70	0.76	1.38
Current Ratio	2.08	1.69	1.51	1.03	1.09	1.99
Return on Equity (ROE)	0.05%	1.16%	2.77%	41.95%	30.80%	13.05%
Return on Assets (ROA)	1.76%	1.88%	1.73%	1.72%	-1.73%	-1.01%
Return on Invested Capital (ROIC)	3.83%	4.40%	2.86%	3.14%	-3.55%	-2.30%
Return on Capital Employed (ROCE)	3.30%	3.60%	3.30%	3.00%	-3.30%	-1.90%
Earnings Yield	0.13%	3.76%	5.47%	66.43%	20.35%	5.56%
FCF Yield	-2.17%	1.98%	2.85%	-10.63%	-14.40%	-1.00%
Buyback Yield / Dilution	-0.11%	-4.74%	3.68%	-16.09%	-23.81%	-30.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.